The central rationale underlying this proposal is that inflammatory reactions in the lung usually resolve. Accordingly, the progressive inflammatory and fibrotic reactions seen as interstitial lung diseases would represent some alteration or defect of this resolution process. We will study resolution and progression of pulmonary inflammation by comparing self- limiting, subacute or progressive and fibrotic reactions in the rabbit. Radiolabelled neutrophils and monocytes will be used to investigate mechanisms by which the accumulation of these cell types ceases or progresses. Routes and rates of clearance of inflammatory cells from the lung will be studied, thus providing data on the inflammatory cell load at any one time. Additionally, since senescent neutrophils have been shown to be ingested by fibroblasts in vitro, we will determine if this represents a route of clearance in vivo, and in particular if such ingestion alters the function of the fibroblasts. Investigation of progression of pulmonary inflammation will focus on mechanisms by which inflammatory cell emigration is maintained. In particular we will examine the possibility that fragmentation of connective tissue proteins provides a persistent source of chemoattractants for monocyte. Finally, two possibilities relating inflammatory processes to fibrosis will be tested: 1) that neutrophil influx is profibrogenic and 2) that the extent of deepithelialization induced by the inflammation or initial injurious factor, dictates the degree of fibrosis. The use of methodology in this project for detailed examination of inflammatory cell trafficking, biochemical and physiologic assessment, lavage, histology and morphometry will also allow specific intervention studies to be carried out in such a fashion as to determine not only their effect on outocome but also on the earlier pathogenetic events which led to this. The project involves extensive interaction with all the other portions of the SCOR and makes major use of the Morphology Core. In particular we hope to define mechanisms and methodology in the experimental animal which we will extend into the patients with project 1 a) to determine elements of pathogenesis and b) to assess the stage of the disease and thus provide rationale or appropriate therapy.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL027353-09
Application #
3879917
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1990
Total Cost
Indirect Cost
Name
National Jewish Health
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206
Kinder, Brent W; Brown, Kevin K; McCormack, Francis X et al. (2009) Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 135:1557-1563
Kinder, Brent W; Brown, Kevin K; Schwarz, Marvin I et al. (2008) Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest 133:226-32
Perez, Rafael L; Kimani, Anthony P; King Jr, Talmadge E et al. (2007) Bronchoalveolar lavage fluid D dimer levels are higher and more prevalent in black patients with pulmonary sarcoidosis. Respiration 74:297-303
Schwarz, Marvin I; Albert, Richard K (2004) ""Imitators"" of the ARDS: implications for diagnosis and treatment. Chest 125:1530-5
Vourlekis, Jason S; Schwarz, Marvin I; Cool, Carlyne D et al. (2002) Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis. Am J Med 112:490-3
Inoue, Yoshikazu; King Jr, Talmadge E; Barker, Elizabeth et al. (2002) Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Am J Respir Crit Care Med 166:765-73
King Jr, T E; Schwarz, M I; Brown, K et al. (2001) Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 164:1025-32
King Jr, T E; Tooze, J A; Schwarz, M I et al. (2001) Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164:1171-81
Glazer, C S; Cohen, L B; Schwarz, M I (2001) Acute eosinophilic pneumonia in AIDS. Chest 120:1732-5
Martinez, J A; Nishimura, C; Guatura, S B et al. (2001) Elevation of soluble interleukin-2 receptor levels in the bronchoalveolar lavage from patients with systemic sclerosis. Rheumatol Int 21:122-6

Showing the most recent 10 out of 220 publications